López-Marte, P., & Rosado-Carrión, B. (2023). Grade 3 Severe Liver Injury Secondary to Pembrolizumab. Puerto Rico Health Sciences Journal, 42(3), 254–255. Retrieved from https://prhsj.rcm.upr.edu/index.php/prhsj/article/view/2954